EnteroBiotix at BioEquity 2023

Past events
Written By James McIlroy

Hear our CEO Dr James McIlroy as he presents at BioEquity this May covering the potential of our premier full-spectrum, microbiome product platform which prevents and treats disease through the restoration and enhancement of gut microbial ecology.

James joins BioCentury for one of Europe’s biggest biotech and investor event to seek opportunities for partnering and investment. Get in touch today to meet James and hear about our transformative microbiome medicine:

Interested in learning more? Reach out to partnering@enterobiotix.com to arrange a meeting.

James McIlroy
Previous

EnteroBiotix appoints Elmar Schnee as Executive Chairman
Next

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy